English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Fighting Drug Counterfeiting

Sep. 29, 2011

The SFDA has tightened some regulations on contract manufacturing organizations (CMOs), notably on rules governing cross-border interactions. Most significantly, the SFDA will no longer allow third parties to operate between a CMO and the pharma company that holds the marketing right for a product. The contact between the CMO and a foreign pharma company must be direct.